CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-04 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) | −6,458 | 0 | ||
| 2024-05-31 | Matsuda Masaru | Purchase | +4,000 | $1.69 | $7K | 185,373 |
| 2024-05-31 | Watanabe Todd Franklin | Purchase | +4,000 | $1.69 | $7K | 836,392 |
| 2024-05-30 | Burnett Patrick | Exercise or conversion | +23,000 | 232,793 | ||
| 2024-05-30 | Burnett Patrick | Sale | −23,000 | $8.75 | $201K | 209,793 |
| 2024-05-30 | Burnett Patrick | Exercise or conversion · Stock Option (right to buy) | −23,000 | 253,000 | ||
| 2024-05-29 | Burnett Patrick | Sale | −49,952 | $8.72 | $435K | 209,793 |
| 2024-05-28 | Matsuda Masaru | Sale 10b5-1 | −1,775 | $9.01 | $16K | 188,508 |
| 2024-05-27 | Matsuda Masaru | Grant or award 10b5-1 | +4,875 | 190,283 | ||
| 2024-05-17 | Edwards Larry Todd SVP Chief Commercial Officer | Sale | −7,640 | $8.98 | $69K | 140,360 |
| 2024-05-16 | Edwards Larry Todd SVP Chief Commercial Officer | Grant or award | +60,000 | 148,000 | ||
| 2024-05-02 | Moore Matthew Richard SVP and Chief Business Officer | Sale 10b5-1 | −4,681 | $8.74 | $41K | 145,505 |
| 2024-05-02 | Watanabe Todd Franklin | Sale 10b5-1 | −13,783 | $8.74 | $120K | 860,750 |
| 2024-05-02 | Matsuda Masaru | Sale 10b5-1 | −5,016 | $8.74 | $44K | 185,408 |
| 2024-05-02 | Burnett Patrick | Sale 10b5-1 | −9,555 | $8.74 | $83K | 259,745 |
| 2024-05-01 | Moore Matthew Richard SVP and Chief Business Officer | Grant or award 10b5-1 | +4,166 | 150,186 | ||
| 2024-04-10 | Topper David Joseph Chief Financial Officer | Grant or award | +110,000 | 110,000 | ||
| 2024-04-10 | Topper David Joseph Chief Financial Officer | Grant or award · Stock Option (right to buy) | +310,000 | 310,000 | ||
| 2024-03-04 | Matsuda Masaru | Sale 10b5-1 | −3,760 | $11.12 | $42K | 190,424 |
| 2024-03-04 | Burnett Patrick | Sale 10b5-1 | −4,782 | $11.12 | $53K | 269,300 |
Page 19 of 35 · 689 trades